AVBP
ArriVent BioPharma, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:40:40 AM EST
10.88USD-0.183%(-0.02)31,767
AVBP Financials
In Q3 FY 2026 (ended ), ArriVent BioPharma, Inc. Common Stock (AVBP) reported revenue of $5M, net income of −$40.31M, operating cash flow of −$40.71M, and assets of $417.09M (filed ).
Loading financial statements…